✦ LIBER ✦

Premalignant and malignant cells in sputum from lung cancer patients

✍ Scribed by Thomas Neumann; Michael Meyer; Florence W. Patten; Fred L. Johnson; Yener S. Erozan; William J. Frable; Prabodh K. Gupta; Muhammad B. Zaman; Alan C. Nelson

Publisher: Wiley (John Wiley & Sons)
Year: 2009
Tongue: English
Weight: 190 KB
Volume: 117
Category: Article
ISSN: 1934-662X
DOI: 10.1002/cncy.20052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Magnetic enrichment of bronchial epithel

Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis

✍ Qiu, Qi ;Todd, Nevins W. ;Li, Ruiyun ;Peng, Hong ;Liu, Zhenqiu ;Yfantis, Harris 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

K-ras mutation in sputum of patients wit

K-ras mutation in sputum of patients with or without lung cancer

✍ Ze'ev Ronai; Marina S. Yabubovskaya; Edith Zhang; Gennady A. Belitsky 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

K-ras mutation appears in about 60% of patients with non-small-cell lung cancer (NSCLC). This freqLency and its presence in normal appearing tissues point to the potential of ras oncogene mutation to serve as a good biomarker. Using enriched PCR (EPCR), which enables the detection of one mutant alle

Serum alpha1-antitrypsin in patients wit

Serum alpha1-antitrypsin in patients with lung cancer or abnormal sputum cytology

✍ Curtis C. Harris; Martin H. Cohen; Robert Connor; Aron Primack; Geno Saccomanno; 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

Sensitive detection of rare cancer cells

Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR

✍ Jeannine Lacroix; Heinrich D. Becker; Stefan M. Woerner; Werner Rittgen; Peter D 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 123 KB 👁 2 views

Analysis of p53 mutations in histologica

Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients

✍ Weimin Gao; Hussam H. Mady; Mona F. Melhem; Phouthone Keohavong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract Our previous study showed a characteristic p53 mutational spectrum in lung tumors from lung cancer patients in the Western Pennsylvania region. To further understand the involvement of p53 mutations in lung tumor development, in this study we compared p53 mutational spectra and distribu

Pretreatment prognostic factors and scor

Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients

✍ T. Cerny; H. Anderson; V. Bramwell; N. Thatcher; V. Blair 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 409 KB 👁 1 views

In 407 patients with small-cell lung cancer (SCLC), 61 pretreatment variables were evaluated in a Cox multiple regression analysis to assess their prognostic value. All patients received short-term intensive regimens (cyclophosphamide, etoposide and methotrexate or ifosfamide and etoposide, both fol